Varun Monga, MBBS

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address550 16th Street, #6669
San Francisco CA 94158
Phone--
ORCID ORCID Icon0000-0002-1185-5448 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Rajiv Gandhi Medical College , Thane, IndiaMBBS04/2006Medical School
    Rosalind Franklin University of Medicine and Science, North Chicago, IL06/2010Internal Medicine Residency
    Rosalind Franklin University of Medicine and Science, North Chicago, IL06/2011Chief Medicine Residency
    University of Iowa, Iowa City, IA06/2016Hematology/Oncology and Bone Marrow Transplantation Fellowship

    Collapse Overview 
    Collapse Overview
    Dr. Varun Monga is a Board Certified Medical Oncologist who serves as an Clinical Associate Professor of Medicine in the Division of Hematology and Oncology. He joined UCSF Medical Center in 2023 and he provides patient care services limited to UCSF Sarcoma Center and Cancer Clinical Trials and Investigational Treatments Center. Dr. Monga has contributed to numerous research articles published in peer-reviewed journals, focusing on evidence-based sarcoma management, early and late phase clinical trials using novel treatment approaches including targeted and immunotherapies.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Collaboration Interests

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Objective Responses in Metastatic Pleomorphic Rhabdomyosarcoma Treated with Combination of Doxorubicin and Pembrolizumab: A Case Series. Case Rep Oncol. 2024 Jan-Dec; 17(1):344-351. Kournoutas I, Monga V, Davick J, Rieth J. PMID: 38404403; PMCID: PMC10890802.
      View in: PubMed   Mentions:
    2. Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM. Clin Cancer Res. 2024 01 17; 30(2):283-293. Petronek MS, Monga V, Bodeker KL, Kwofie M, Lee CY, Mapuskar KA, Stolwijk JM, Zaher A, Wagner BA, Smith MC, Vollstedt S, Brown H, Chandler ML, Lorack AC, Wulfekuhle JS, Sarkaria JN, Flynn RT, Greenlee JDW, Howard MA, Smith BJ, Jones KA, Buettner GR, Cullen JJ, St-Aubin J, Buatti JM, Magnotta VA, Spitz DR, Allen BG. PMID: 37773633; PMCID: PMC10841843.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    3. PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study. Oral Oncol. 2024 Feb; 149:106634. Ferrarotto R, Swiecicki PL, Zandberg DP, Baiocchi RA, Wesolowski R, Rodriguez CP, McKean M, Kang H, Monga V, Nath R, Palmisiano N, Babbar N, Sun W, Hanna GJ. PMID: 38118249.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    4. T2* Imaging Assessment of Neoadjuvant Radiation Therapy Combined With Pharmacological Ascorbate in Extremity Soft-Tissue Sarcomas: A Pilot Study. Iowa Orthop J. 2023 Dec; 43(2):60-69. Lee CY, Petronek MS, Monga V, Miller BJ, Milhem MM, Magnotta VA, Allen BG. PMID: 38213860; PMCID: PMC10777695.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression. Clin Cancer Res. 2023 09 01; 29(17):3484-3497. Kohlmeyer JL, Lingo JJ, Kaemmer CA, Scherer A, Warrier A, Voigt E, Raygoza Garay JA, McGivney GR, Brockman QR, Tang A, Calizo A, Pollard K, Zhang X, Hirbe AC, Pratilas CA, Leidinger M, Breheny P, Chimenti MS, Sieren JC, Monga V, Tanas MR, Meyerholz DK, Darbro BW, Dodd RD, Quelle DE. PMID: 37410426; PMCID: PMC10528807.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    6. Gaps in Adolescent and Young Adult Cancer Education in Oncology Fellowship Training. J Adolesc Young Adult Oncol. 2024 Feb; 13(1):97-104. Moerdler S, DuVall AS, Hayes-Lattin B, Grimes A, Prasad PK, Molina JC, Monga V, Freyer DR, Roth ME. PMID: 37477884.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. The Midwest Sarcoma Trials Partnership: Bridging Academic and Community Networks in a Collaborative Approach to Sarcoma. J Clin Med. 2023 Mar 29; 12(7). Heater NK, Okuno S, Robinson S, Attia S, Seetharam M, Siontis BL, Yoon J, Chawla S, Milhem MM, Monga V, Skubitz K, Charlson J, Hirbe AC, Weiss MC, Van Tine B, Agulnik M. PMID: 37048645; PMCID: PMC10095464.
      View in: PubMed   Mentions: 1  
    8. Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial. Neuro Oncol. 2023 01 05; 25(1):146-156. de la Fuente MI, Colman H, Rosenthal M, Van Tine BA, Levacic D, Walbert T, Gan HK, Vieito M, Milhem MM, Lipford K, Forsyth S, Guichard SM, Mikhailov Y, Sedkov A, Brevard J, Kelly PF, Mohamed H, Monga V. PMID: 35639513; PMCID: PMC9825299.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    9. Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients. Redox Biol. 2023 04; 60:102599. Mapuskar KA, Vasquez Martinez G, Pulliam CF, Petronek MS, Steinbach EJ, Monga V, Furqan M, Jetton JG, Saunders DP, Pearce A, Davidson S, Pitre L, Dunlap NE, Fairbanks R, Lee CM, Mott SL, Bodeker KL, Cl H, Buatti JM, Anderson CM, Beardsley RA, Holmlund JT, Zepeda-Orozco D, Spitz DR, Allen BG. PMID: 36640725; PMCID: PMC9852651.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    10. Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism. JCI Insight. 2022 11 22; 7(22). Gutierrez WR, Scherer A, Rytlewski JD, Laverty EA, Sheehan AP, McGivney GR, Brockman QR, Knepper-Adrian V, Roughton GA, Quelle DE, Gordon DJ, Monga V, Dodd RD. PMID: 36227698; PMCID: PMC9746804.
      View in: PubMed   Mentions: 4     Fields:    Translation:AnimalsCells
    11. Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations. J Clin Oncol. 2023 01 20; 41(3):618-628. Brastianos PK, Twohy EL, Gerstner ER, Kaufmann TJ, Iafrate AJ, Lennerz J, Jeyapalan S, Piccioni DE, Monga V, Fadul CE, Schiff D, Taylor JW, Chowdhary SA, Bettegowda C, Ansstas G, De La Fuente M, Anderson MD, Shonka N, Damek D, Carrillo J, Kunschner-Ronan LJ, Chaudhary R, Jaeckle KA, Senecal FM, Kaley T, Morrison T, Thomas AA, Welch MR, Iwamoto F, Cachia D, Cohen AL, Vora S, Knopp M, Dunn IF, Kumthekar P, Sarkaria J, Geyer S, Carrero XW, Martinez-Lage M, Cahill DP, Brown PD, Giannini C, Santagata S, Barker FG, Galanis E. PMID: 36288512; PMCID: PMC9870228.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    12. The Impact of TSC-1 and -2 Mutations on Response to Therapy in Malignant PEComa: A Multicenter Retrospective Analysis. Genes (Basel). 2022 10 24; 13(11). Liu L, Dehner C, Grandhi N, Lyu Y, Borcherding DC, Chrisinger JSA, Zhang X, Luo J, Tao Y, Parkes A, Bui NQ, Davis EJ, Milhem MM, Monga V, Weiss M, Tine BV, Hirbe AC. PMID: 36360169; PMCID: PMC9689779.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Patient reported quality of life in young adults with sarcoma receiving care at a sarcoma center. Front Psychol. 2022; 13:871254. Day JR, Miller B, Loeffler BT, Mott SL, Tanas M, Curry M, Davick J, Milhem M, Monga V. PMID: 36248560; PMCID: PMC9559373.
      View in: PubMed   Mentions: 1  
    14. Pharmacological ascorbate as a novel therapeutic strategy to enhance cancer immunotherapy. Front Immunol. 2022; 13:989000. Zaher A, Stephens LM, Miller AM, Hartwig SM, Stolwijk JM, Petronek MS, Zacharias ZR, Wadas TJ, Monga V, Cullen JJ, Furqan M, Houtman JCD, Varga SM, Spitz DR, Allen BG. PMID: 36072595; PMCID: PMC9444023.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    15. Detection of Ferritin Expression in Soft Tissue Sarcomas With MRI: Potential Implications for Iron Metabolic Therapy. Iowa Orthop J. 2022 06; 42(1):255-262. Petronek MS, Tomanek-Chalkley AM, Monga V, Milhem MM, Miller BJ, Magnotta VA, Allen BG. PMID: 35821920; PMCID: PMC9210395.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    16. Pharmacological ascorbate improves the response to platinum-based chemotherapy in advanced stage non-small cell lung cancer. Redox Biol. 2022 07; 53:102318. Furqan M, Abu-Hejleh T, Stephens LM, Hartwig SM, Mott SL, Pulliam CF, Petronek M, Henrich JB, Fath MA, Houtman JC, Varga SM, Bodeker KL, Bossler AD, Bellizzi AM, Zhang J, Monga V, Mani H, Ivanovic M, Smith BJ, Byrne MM, Zeitler W, Wagner BA, Buettner GR, Cullen JJ, Buatti JM, Spitz DR, Allen BG. PMID: 35525024; PMCID: PMC9079696.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    17. Sexual Dysfunction Among Adolescent and Young Adult Men Diagnosed with Cancer. J Adolesc Young Adult Oncol. 2023 02; 12(1):93-100. Rainer QC, Dubin JM, Balaji NC, Troesch V, Terry W, Monga V, Clifford L, Shoag J, Greer A, Nackeeran S, Rodriguez AA, Patel P, Paz L, Kava BR, Alperstein W, Pearlman AM, Ramasamy R. PMID: 35319264.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Shared barriers and facilitators to enrollment of adolescents and young adults on cancer clinical trials. Sci Rep. 2022 03 09; 12(1):3875. Mittal N, Saha A, Avutu V, Monga V, Freyer DR, Roth M. PMID: 35264642; PMCID: PMC8907177.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    19. Epigenetic modulation in sensitizing metastatic sarcomas to therapies and overcoming resistance. Cancer Drug Resist. 2022; 5(1):25-35. Rytlewski J, Brockman QR, Dodd RD, Milhem M, Monga V. PMID: 35582536; PMCID: PMC8992584.
      View in: PubMed   Mentions: 1  
    20. Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma. Antioxidants (Basel). 2021 Dec 14; 10(12). Flor S, Oliva CR, Ali MY, Coleman KL, Greenlee JD, Jones KA, Monga V, Griguer CE. PMID: 34943091; PMCID: PMC8750785.
      View in: PubMed   Mentions: 8  
    21. Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children's Oncology Group Adolescent and Young Adult Responsible Investigator Network. JCO Oncol Pract. 2022 03; 18(3):224-231. Avutu V, Monga V, Mittal N, Saha A, Andolina JR, Bell DE, Fair DB, Flerlage JE, Frediani JN, Heath JL, Kahn JM, Reichek JL, Super L, Terao MA, Freyer DR, Roth ME. PMID: 34905405; PMCID: PMC8932547.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    22. An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma. Eur J Cancer. 2021 09; 154:201-208. Agulnik M, Schulte B, Robinson S, Hirbe AC, Kozak K, Chawla SP, Attia S, Rademaker A, Zhang H, Abbinanti S, Cehic R, Monga V, Milhem M, Okuno S, Van Tine BA. PMID: 34284255.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCTClinical Trials
    23. Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trial. J Immunother Cancer. 2021 07; 9(7). Monga V, Miller BJ, Tanas M, Boukhar S, Allen B, Anderson C, Stephens L, Hartwig S, Varga S, Houtman J, Wang L, Zhang W, Jaber O, Thomason J, Kuehn D, Rajput M, Metz C, Zamba KD, Mott S, Abanonu C, Bhatia S, Milhem M. PMID: 34330766; PMCID: PMC8327848.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    24. Turning 'Cold' tumors 'Hot': immunotherapies in sarcoma. Ann Transl Med. 2021 Jun; 9(12):1039. Rytlewski J, Milhem MM, Monga V. PMID: 34277839; PMCID: PMC8267323.
      View in: PubMed   Mentions: 16  
    25. Phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas. Br J Cancer. 2021 08; 125(4):528-533. Schulte B, Mohindra N, Milhem M, Attia S, Robinson S, Monga V, Hirbe AC, Oppelt P, Charlson J, Helenowski I, Abbinanti S, Cehic R, Okuno S, Van Tine BA, Agulnik M. PMID: 34050255; PMCID: PMC8368095.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    26. Radiomic Based Machine Learning Performance for a Three Class Problem in Neuro-Oncology: Time to Test the Waters? Cancers (Basel). 2021 May 24; 13(11). Priya S, Liu Y, Ward C, Le NH, Soni N, Pillenahalli Maheshwarappa R, Monga V, Zhang H, Sonka M, Bathla G. PMID: 34073840; PMCID: PMC8197204.
      View in: PubMed   Mentions: 6  
    27. Machine learning based differentiation of glioblastoma from brain metastasis using MRI derived radiomics. Sci Rep. 2021 05 18; 11(1):10478. Priya S, Liu Y, Ward C, Le NH, Soni N, Pillenahalli Maheshwarappa R, Monga V, Zhang H, Sonka M, Bathla G. PMID: 34006893; PMCID: PMC8131619.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    28. Radiomics-based differentiation between glioblastoma and primary central nervous system lymphoma: a comparison of diagnostic performance across different MRI sequences and machine learning techniques. Eur Radiol. 2021 Nov; 31(11):8703-8713. Bathla G, Priya S, Liu Y, Ward C, Le NH, Soni N, Maheshwarappa RP, Monga V, Zhang H, Sonka M. PMID: 33890149.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    29. Glioblastoma and primary central nervous system lymphoma: differentiation using MRI derived first-order texture analysis - a machine learning study. Neuroradiol J. 2021 Aug; 34(4):320-328. Priya S, Ward C, Locke T, Soni N, Maheshwarappa RP, Monga V, Agarwal A, Bathla G. PMID: 33657924; PMCID: PMC8447821.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    30. Photodynamic Therapy Using Hippo Pathway Inhibitor Verteporfin: A Potential Dual Mechanistic Approach in Treatment of Soft Tissue Sarcomas. Cancers (Basel). 2021 Feb 08; 13(4). Rytlewski JD, Scalora N, Garcia K, Tanas M, Toor F, Miller B, Allen B, Milhem M, Monga V. PMID: 33567506; PMCID: PMC7915813.
      View in: PubMed   Mentions: 3  
    31. Survival prediction in glioblastoma on post-contrast magnetic resonance imaging using filtration based first-order texture analysis: Comparison of multiple machine learning models. Neuroradiol J. 2021 Aug; 34(4):355-362. Priya S, Agarwal A, Ward C, Locke T, Monga V, Bathla G. PMID: 33533273; PMCID: PMC8447822.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    32. Testosterone deficiency in men receiving immunotherapy for malignant melanoma. Oncotarget. 2021 Feb 02; 12(3):199-208. Peters M, Pearlman A, Terry W, Mott SL, Monga V. PMID: 33613847; PMCID: PMC7869578.
      View in: PubMed   Mentions: 6     Fields:    
    33. Combination therapies for MPNSTs targeting RABL6A-RB1 signaling. Oncotarget. 2021 Jan 05; 12(1):10-14. Kohlmeyer JL, Gordon DJ, Tanas MR, Dodd RD, Monga V, Darbro BW, Quelle DE. PMID: 33456709; PMCID: PMC7800773.
      View in: PubMed   Mentions: 7     Fields:    
    34. Magnetic resonance imaging (MRI) of pharmacological ascorbate-induced iron redox state as a biomarker in subjects undergoing radio-chemotherapy. Redox Biol. 2021 01; 38:101804. Cushing CM, Petronek MS, Bodeker KL, Vollstedt S, Brown HA, Opat E, Hollenbeck NJ, Shanks T, Berg DJ, Smith BJ, Smith MC, Monga V, Furqan M, Howard MA, Greenlee JD, Mapuskar KA, St-Aubin J, Flynn RT, Cullen JJ, Buettner GR, Spitz DR, Buatti JM, Allen BG, Magnotta VA. PMID: 33260088; PMCID: PMC7708874.
      View in: PubMed   Mentions: 8     Fields:    Translation:Cells
    35. Radioresistance in Glioblastoma and the Development of Radiosensitizers. Cancers (Basel). 2020 Sep 03; 12(9). Ali MY, Oliva CR, Noman ASM, Allen BG, Goswami PC, Zakharia Y, Monga V, Spitz DR, Buatti JM, Griguer CE. PMID: 32899427; PMCID: PMC7564557.
      View in: PubMed   Mentions: 47  
    36. Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective Agents. Cancers (Basel). 2020 Aug 12; 12(8). Callaghan CM, Hasibuzzaman MM, Rodman SN, Goetz JE, Mapuskar KA, Petronek MS, Steinbach EJ, Miller BJ, Pulliam CF, Coleman MC, Monga VV, Milhem MM, Spitz DR, Allen BG. PMID: 32806601; PMCID: PMC7465163.
      View in: PubMed   Mentions: 5  
    37. The Effect of Concurrent Stereotactic Body Radiation and Anti-PD-1 Therapy for Recurrent Metastatic Sarcoma. Radiat Res. 2020 08 01; 194(2):124-132. Callaghan CM, Seyedin SN, Mohiuddin IH, Hawkes KL, Petronek MS, Anderson CM, Buatti JM, Milhem MM, Monga V, Allen BG. PMID: 32845986; PMCID: PMC10443123.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    38. A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy. Eur J Cancer. 2020 09; 137:1-9. Hirbe AC, Eulo V, Moon CI, Luo J, Myles S, Seetharam M, Toeniskoetter J, Kershner T, Haarberg S, Agulnik M, Monga V, Milhem M, Parkes A, Robinson S, Okuno S, Attia S, Van Tine BA. PMID: 32712457.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    39. Non-Conventional Treatments for Conventional Chondrosarcoma. Cancers (Basel). 2020 Jul 19; 12(7). Monga V, Mani H, Hirbe A, Milhem M. PMID: 32707689; PMCID: PMC7409290.
      View in: PubMed   Mentions: 13  
    40. A Retrospective Analysis of the Efficacy of Immunotherapy in Metastatic Soft-Tissue Sarcomas. Cancers (Basel). 2020 Jul 11; 12(7). Monga V, Skubitz KM, Maliske S, Mott SL, Dietz H, Hirbe AC, Van Tine BA, Oppelt P, Okuno S, Robinson S, O'Connor M, Seetharam M, Attia S, Charlson J, Agulnik M, Milhem M. PMID: 32664595; PMCID: PMC7408640.
      View in: PubMed   Mentions: 24  
    41. CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets. Int J Mol Sci. 2020 Apr 24; 21(8). Kohlmeyer JL, Gordon DJ, Tanas MR, Monga V, Dodd RD, Quelle DE. PMID: 32344731; PMCID: PMC7215455.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    42. A Retrospective Analysis of Clinical Trial Accrual of Patients Presented in a Multidisciplinary Tumor Board at a Tertiary Health Care Center and Associated Barriers. Oncol Res Treat. 2020; 43(5):196-203. Mobley EM, Swami U, Mott S, Ounda A, Milhem M, Monga V. PMID: 32222709; PMCID: PMC8188843.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    43. Survival after reoperation for recurrent glioblastoma. J Clin Neurosci. 2020 Mar; 73:118-124. Woodroffe RW, Zanaty M, Soni N, Mott SL, Helland LC, Pasha A, Maley J, Dhungana N, Jones KA, Monga V, Greenlee JDW. PMID: 31987636.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    44. Dermatofibrosarcoma protuberans - the use of neoadjuvant imatinib for treatment of an uncommon breast malignancy: a case report. J Med Case Rep. 2019 Dec 19; 13(1):374. McGee MW, Boukhar SA, Monga V, Weigel R, Phadke SD. PMID: 31852518; PMCID: PMC6921555.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. Exceptional responses with sequential metronomic temozolomide after pembrolizumab failure in patients with metastatic melanoma. Melanoma Res. 2019 12; 29(6):643-647. Swami U, Monga V, Freesmeier M, Zhang W, Bossler AD, Zakharia Y, Milhem M. PMID: 30829928; PMCID: PMC6717692.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    46. Factors Impacting Fertility Preservation in Adolescents and Young Adults with Cancer: A Retrospective Study. J Adolesc Young Adult Oncol. 2020 04; 9(2):208-221. Mobley EM, Ryan GL, Sparks AE, Monga V, Terry WW. PMID: 31651207; PMCID: PMC7360112.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    47. First-in-Human Phase I Clinical Trial of Pharmacologic Ascorbate Combined with Radiation and Temozolomide for Newly Diagnosed Glioblastoma. Clin Cancer Res. 2019 11 15; 25(22):6590-6597. Allen BG, Bodeker KL, Smith MC, Monga V, Sandhu S, Hohl R, Carlisle T, Brown H, Hollenbeck N, Vollstedt S, Greenlee JD, Howard MA, Mapuskar KA, Seyedin SN, Caster JM, Jones KA, Cullen JJ, Berg D, Wagner BA, Buettner GR, TenNapel MJ, Smith BJ, Spitz DR, Buatti JM. PMID: 31427282; PMCID: PMC6858950.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    48. Timing of surgery following neoadjuvant chemoradiation in rectal cancer: a retrospective analysis from an academic medical center. J Gastrointest Oncol. 2019 Aug; 10(4):597-604. Maliske S, Chau J, Ginader T, Byrn J, Bhatia S, Bellizzi A, Berg DJ, Monga V. PMID: 31392039; PMCID: PMC6657321.
      View in: PubMed   Mentions: 3  
    49. Durable Clinical Benefit in Patients with Advanced Cutaneous Melanoma after Discontinuation of Anti-PD-1 Therapies Due to Immune-Related Adverse Events. J Oncol. 2019; 2019:1856594. Swami U, Monga V, Bossler AD, Zakharia Y, Milhem M. PMID: 31428149; PMCID: PMC6683789.
      View in: PubMed   Mentions: 11  
    50. Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapy. Eur J Cancer Care (Engl). 2019 Mar; 28(2):e12973. Monga V, Maliske SM, Kaleem H, Mott SL, K D Zamba G, Milhem M. PMID: 30511450; PMCID: PMC6416062.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    51. Improved survival for extremity soft tissue sarcoma treated in high-volume facilities. J Surg Oncol. 2018 Jun; 117(7):1479-1486. Abarca T, Gao Y, Monga V, Tanas MR, Milhem MM, Miller BJ. PMID: 29633281; PMCID: PMC6322682.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    52. Financial impact of oral chemotherapy wastage on society and the patient. J Oncol Pharm Pract. 2019 Jun; 25(4):824-830. Monga V, Meyer C, Vakiner B, Clamon G. PMID: 29575989; PMCID: PMC7293877.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    53. Biallelic TP53 gain of function mutations in rapidly progressing solid tumors. Cancer Genet. 2018 04; 222-223:20-24. Sande CM, Chang B, Monga V, Bossler AD, Ma D. PMID: 29666004.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    54. A Phase I/II Study Targeting Angiogenesis Using Bevacizumab Combined with Chemotherapy and a Histone Deacetylase Inhibitor (Valproic Acid) in Advanced Sarcomas. Cancers (Basel). 2018 Feb 17; 10(2). Monga V, Swami U, Tanas M, Bossler A, Mott SL, Smith BJ, Milhem M. PMID: 29462961; PMCID: PMC5836085.
      View in: PubMed   Mentions: 12  
    55. Gastrointestinal stromal tumors-are we stuck and the way forward. Transl Gastroenterol Hepatol. 2017; 2:93. Swami U, Monga V, Milhem M. PMID: 29264431; PMCID: PMC5723736.
      View in: PubMed   Mentions:
    56. Redox active metals and H2O2 mediate the increased efficacy of pharmacological ascorbate in combination with gemcitabine or radiation in pre-clinical sarcoma models. Redox Biol. 2018 04; 14:417-422. Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Bradley MD, Wagner BA, Buettner GR, Monga V, Milhem M, Spitz DR, Allen BG. PMID: 29069637; PMCID: PMC5651553.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    57. Targeting epigenetics for treatment of BRAF mutated metastatic melanoma with decitabine in combination with vemurafenib: A phase lb study. Oncotarget. 2017 Oct 24; 8(51):89182-89193. Zakharia Y, Monga V, Swami U, Bossler AD, Freesmeier M, Frees M, Khan M, Frydenlund N, Srikantha R, Vanneste M, Henry M, Milhem M. PMID: 29179510; PMCID: PMC5687680.
      View in: PubMed   Mentions: 18     Fields:    
    58. O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. Cancer Cell. 2017 08 14; 32(2):268. Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Kauffman EPS, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG. PMID: 28810149.
      View in: PubMed   Mentions: 54     Fields:    
    59. Mitochondrial Superoxide Increases Age-Associated Susceptibility of Human Dermal Fibroblasts to Radiation and Chemotherapy. Cancer Res. 2017 09 15; 77(18):5054-5067. Mapuskar KA, Flippo KH, Schoenfeld JD, Riley DP, Strack S, Hejleh TA, Furqan M, Monga V, Domann FE, Buatti JM, Goswami PC, Spitz DR, Allen BG. PMID: 28765155; PMCID: PMC5600863.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    60. Fatal pulmonary embolism following splenectomy in a patient with Evan's syndrome: case report and review of the literature. Thromb J. 2017; 15:18. Monga V, Maliske SM, Perepu U. PMID: 28680366; PMCID: PMC5496165.
      View in: PubMed   Mentions: 1  
    61. O2⋅- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. Cancer Cell. 2017 04 10; 31(4):487-500.e8. Schoenfeld JD, Sibenaller ZA, Mapuskar KA, Wagner BA, Cramer-Morales KL, Furqan M, Sandhu S, Carlisle TL, Smith MC, Abu Hejleh T, Berg DJ, Zhang J, Keech J, Parekh KR, Bhatia S, Monga V, Bodeker KL, Ahmann L, Vollstedt S, Brown H, Shanahan Kauffman EP, Schall ME, Hohl RJ, Clamon GH, Greenlee JD, Howard MA, Schultz MK, Smith BJ, Riley DP, Domann FE, Cullen JJ, Buettner GR, Buatti JM, Spitz DR, Allen BG. PMID: 28366679; PMCID: PMC5497844.
      View in: PubMed   Mentions: 159     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    62. Ipilimumab: from preclinical development to future clinical perspectives in melanoma. Future Oncol. 2017 Mar; 13(7):625-636. Letendre P, Monga V, Milhem M, Zakharia Y. PMID: 27882779; PMCID: PMC5618953.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    63. Metastatic Adenoid Cystic Carcinoma of the Breast. Breast J. 2016 Mar-Apr; 22(2):239-40. Monga V, Leone JP. PMID: 26684244; PMCID: PMC5292235.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Pulmonary extramedullary hematopoiesis involving the pulmonary artery. Hematol Rep. 2015 Feb 24; 7(1):5714. Monga V, Silverman M. PMID: 25852851; PMCID: PMC4378208.
      View in: PubMed   Mentions: 5  
    65. Multiple intra-abdominal masses. Am J Hematol. 2010 Jul; 85(7):515. Yasar DG, Monga V. PMID: 20575018.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Varun's Networks
    Concepts (195)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.